Información del producto
Nombre:Crizotinib hydrochloride
Marca:Biosynth
Descripción:Crizotinib hydrochloride (CZH) is an anti-cancer drug that inhibits the enzyme tyrosine kinase. It is a porphyrin-based molecule that has a linker to crizotinib, a cytotoxic agent. CZH has been approved for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults who have received at least one prior therapy. The effective dose of CZH is 400 mg twice per day. CZH has shown anticancer activity in vitro and in vivo and low toxicity.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:486.8 g/mol
Fórmula:C21H23Cl3FN5O
Pureza:Min. 95%